Tools   Select Another Resource Report Type

http://www.pivotparkscreeningcentre.com/

Commercial organization dedicated to open innovation, providing automated cellular and biochemical in-vitro screening experiments, and ultra-High Throughput Screening (uHTS) services. The Pivot Park facilities include MSD''s former screening centre which comprise two unique robotic systems for in-vitro screening. Because the new screening centre was able to retain a significant number of the original screening staff, it offers a wealth of experience in assay development, screening and automation in a new, open setting.

Proper citation: Pivot Park Screening Centre (RRID:SCR_004115) Copy   

•   Source: SciCrunch Registry
  

http://www.phenosys.com/

A research- and development-oriented company based in Berlin that engineers and markets technology for animal behavior research offering unique, automated instrumentation. This includes specialized applications of virtual reality and touch screen technology for animal behavior environments and RFID (transponder) operated devices in home cage environments. Their experimental systems are used for behavioral phenotyping, brain research, experimental psychology, and the diagnostic characterization of animal models for translational medicine.

Proper citation: PhenoSys (RRID:SCR_004072) Copy   

•   Source: SciCrunch Registry
  

http://www.kribb.re.kr/eng/main/main.jsp

Proper citation: Korea Research Institute of Bioscience and Biotechnology; Daejeon; South Korea (RRID:SCR_004071) Copy   

•   Source: SciCrunch Registry
  

http://www.noldus.com/

Commercial organization that develops tools and systems for measurement and analysis of animal and human behavior. They develop instrumented home cage systems, in which rodent behavior and ultrasonic vocalizations can be measured in a non-intrusive manner. Furthermore, they develop computer vision and pattern recognition technology for automated behavior detection. They believe that this approach has significant potential in research on animal models for Autism Spectrum Disorder.

Proper citation: Noldus (RRID:SCR_004074) Copy   

•   Source: SciCrunch Registry
  

http://iapo.org.uk/

A global alliance representing patients of all nations across all disease areas and promoting patient-centered healthcare across the world. They represent people who suffer from diseases, disabilities, illnesses, impairments or syndromes and work with communities of patients to get their voices heard by all involved in healthcare. With the help of their members and collaborating organizations, they work towards patient-centered healthcare throughout the world.

Proper citation: International Alliance of Patients Organizations (RRID:SCR_004073) Copy   

•   Source: SciCrunch Registry
  

http://www.kyoto-u.ac.jp/en

National university in Kyoto, Japan. It is the second oldest Japanese university, one of Asia highest ranked universities and one of Japan National Seven Universities.

Proper citation: Kyoto University; Kyoto; Japan (RRID:SCR_004108) Copy   

•   Source: SciCrunch Registry
  

http://purl.bioontology.org/ontology/OPB

A reference ontology of classical physics as applied to the dynamics of biological systems. It is designed to encompass the multiple structural scales (multiscale atoms to organisms) and multiple physical domains (multidomain fluid dynamics, chemical kinetics, particle diffusion, etc.) that are encountered in the study and analysis of biological organisms.

Proper citation: Ontology of Physics for Biology (RRID:SCR_004144) Copy   

•   Source: SciCrunch Registry
  

http://www.euadr-project.org/

Consortium that created the capability to detect Adverse Drug Response (ADR) signals by creating the infrastructure for large-scale monitoring of drug safety using electronic health records (EHR). The platform leverages EHR''''s comprising demographics, drug use and clinical data of over 30 million patients from several European countries. Special attention was given to patient groups that are not routinely involved in clinical trials, for ethical or practical reasons (e.g. pregnant women, elderly people, people using many drugs simultaneously, and children). This project also studies and compares a number of different techniques that all aim to detect unexpected or disproportional rates of events. The algorithms that they studied originate not only from the field of (pharmaco)epidemiology, but also from fields such as bio-terrorism, machine learning, and classical signal detection. EU-ADR specific objectives are: To detect events, To relate these events to drugs, To develop hypothesis that explain adverse events, To detect adverse events earlier, and To avoid false positives. The web-based platform is available at https://bioinformatics.ua.pt/euadr/ EU-ADR has contributed to the ability to conduct better drug safety studies based on the re-use of healthcare data. By facilitating the early detection of adverse drug reactions, but also providing key information on populations at risk, potential drug interactions, potential underlying mechanisms and intervening pathways in adverse events, etc., the project will allow for improved and more complete information to be available for drug and healthcare delivery, leading to increased patient safety and its associated cost savings. The EU-ADR system can be considered as a complementary tool to already existing pharamcovigilance systems. Should the system be widespread in the long term, it has the potential to contribute to the development of future electronic health record systems, insofar as the expected benefits of these IT tools are only fully attainable when EHRs develop themselves in consistency, richness and formats that allow them to be subject of such tools. In anticipation, EU-ADR has been designed to be modular and scalable, so that different EHR databases (other than those participating in the Consortium) can be progressively enlisted in the future, adopt the software for data extraction and therefore become susceptible of exploitation by the system, for maximum global effect.

Proper citation: EU-ADR (RRID:SCR_004028) Copy   

•   Source: SciCrunch Registry
  

http://www.ohsu.edu/xd/research/centers-institutes/neurology/alzheimers/

An aging and Alzheimer's disease research center that conducts studies of treatments, technologies for patient support, genetics, neuroimaging, and pathology. The Center's clinical research focuses on understanding differing rates of progression and cognitive decline as compared to optimal cognitive health in the elderly and are currently studying methods of gauging the progression of Alzheimer’s disease through research in genetics, neuroimaging, and cerebrospinal fluid biomarkers. Clinical trials performed at the Center include drugs targeted to ameliorate the symptoms of memory failure and slow the progression of disease.

Proper citation: OHSU Layton Aging and Alzheimer's Disease Center (RRID:SCR_008821) Copy   

•   Source: SciCrunch Registry
  

http://www.med.upenn.edu/cndr/biosamples-brainbank.html

A brain and tissue bank that contains human brain samples from patients with Alzheimer's disease (AD), Parkinson's disease (PD) and other related neurodegenerative dementias and movement disorders. This brain bank serves as a resource for scientists and researchers, providing access to tissue samples for further research. While priority is given to University of Pennsylvania researchers, this bank will provide requests to researchers not associated with the University of Pennsylvania. This tissue bank accepts donations from those seeing a University of Pennsylvania physician or collaborator.

Proper citation: University of Pennslyvania Brain Bank (RRID:SCR_008820) Copy   

•   Source: SciCrunch Registry
  

http://fundingopps.cos.com/news/

A biweekly news feed that includes a sampling of new and updated award information from COS Funding Opportunities. COS Funding Opportunities is the most comprehensive source of funding information available on the Web, with more than 25,000 awards from around the world. For highlights of funding available for the health sciences and for the humanities, check out COS Health Science Funding News and COS Humanities and Social Sciences Funding News. Which funding opportunities are most popular? To find out, see last week''s Top Ten Funding Opportunities. COS Funding News is now available as an RSS feed.

Proper citation: COS Funding News (RRID:SCR_008783) Copy   

•   Source: SciCrunch Registry
  

http://eyewire.org/

An online game for mapping neuronal connections in the retina. The site provides microscopic retinal images and uses crowdsourcing to make sense of the images. EyeWire is where the general public can help make discoveries about the neural structure of the retina. The challenge is to map the neural connections of the retina by analyzing images that were acquired using serial electron microscopy at the Max Planck Institute for Medical Research in Heidelberg, Germany. A retinal volume of size 350��300��60 micrometer cubed was imaged, amounting to about one terabyte of data. Retinal Connectome * Game 1: Reconstructing Neurons * Game 2: Identifying Synapses Eyewire incorporates computational technologies developed by the laboratory of Prof. Sebastian Seung at MIT.

Proper citation: EyeWire (RRID:SCR_008816) Copy   

•   Source: SciCrunch Registry
  

http://www.nia.nih.gov/research/dgcg/clinical-research-study-investigators-toolbox

The purpose of the NIA Clinical Research Toolbox is to provide a Web-based information repository for investigators and staff involved in clinical research. The Toolbox contains templates, sample forms, guidelines, regulations and information materials to assist investigators in the development and conduct of high quality clinical research studies.

Proper citation: Clinical Research Study Investigators Toolbox (RRID:SCR_008815) Copy   

•   Source: SciCrunch Registry
  

http://www.lifetechnologies.com/

Vendor for life sciences products and services ranging from instruments to antibodies.

Proper citation: Life Technologies (RRID:SCR_008817) Copy   

•   Source: SciCrunch Registry
  

http://mayoresearch.mayo.edu/mayo/research/udall_center/

A research program associated with bringing together researchers from various disciplines to study the genetic and molecular basis of Parkinson's disease. The program focuses on epidemiological and longitudinal studies of Parkinson's disease, dementia with Lewy bodies, and aging and dementia. It also provides clinical materials for other research projects. This program provides faculty research funds, invited speaker seminar series, sponsorship of movement disorder fellowships, pilot research grants, and support for faculty travel to promote intra-institutional collaborations.

Proper citation: Udall Center of Excellence in Parkinson's Disease Research (RRID:SCR_008778) Copy   

•   Source: SciCrunch Registry
  

http://www.abfrontier.com/

An Antibody supplier

Proper citation: ABFrontier (RRID:SCR_008899) Copy   

•   Source: SciCrunch Registry
  

http://www.alz.org/research/alzheimers_grants/overview.asp

An organization that funds research for Alzheimer's disease, provides information on new treatment strategies, provides information on caring for afflicted people, and generally increases public knowledge of disease prevention. This program financially supports new Alzheimer's studies. These research projects are selected by the Medical and Scientific Advisory Council. The council chooses which studies to address based on their potential uses in diagnostics, genetics, treatments, prevention, early detection and general enhancement of lifestyle.

Proper citation: Alzheimer's Association International Research Grant Program (RRID:SCR_008775) Copy   

•   Source: SciCrunch Registry
  

http://www.mcknight.org/

An endowment that offers funding for neuroscience research, especially as it may apply to Minnesota, agriculture, or if the researchers are based in Minnesota. The McKnight Foundation, a Minnesota-based family foundation, seeks to improve the quality of life for present and future generations through grantmaking, collaboration, and strategic policy reform in the following areas: arts, education and learning, environment, the region and communities, agricultural research, and neuroscience research. The McKnight Foundation assists nonprofit organizations and public agencies to improve the quality of life for all people, particularly those in need. Through grantmaking, coalition-building, and encouragement of strategic policy reform, we aim to build and maintain vibrant communities; enrich people''s lives through the arts; encourage protection of the natural environment; and promote research in selected fields. The Foundation had assets of approximately $1.8 billion and gave about $98 million in grants in 2009. Generally speaking, McKnight supports nonprofit organizations in Minnesota, U.S., only. McKnight''s primary geographic focus in grantmaking is to nonprofit organizations located within the state of Minnesota. We do not provide funding outside Minnesota, with five important programmatic exceptions: * Collaborative Crop research: International. * East Africa: Tanzania and Uganda only. * Mississippi River: 10 states bordering or encompassing the Mississippi River. * Neuroscience research: National. * Southeast Asia: Cambodia, Laos, and Vietnam only. Each program is different. Please consult the specific guidelines appropriate to your project or organization for funding details. With very few exceptions, McKnight funds nonprofit organizations only. To be eligible for a grant, applicants must be classified by the Internal Revenue Service as tax-exempt, nonprofit organizations. We discourage the use of fiscal agents.

Proper citation: McKnight Foundation (RRID:SCR_008776) Copy   

•   Source: SciCrunch Registry
  

http://www.mcknight.org/neuroscience/

An endowment that offers funding for memory research. The McKnight Endowment Fund for Neuroscience is an independent charitable organization established by The McKnight Foundation to carry out the wishes of its founder, William L. McKnight (1887-1979). Currently, the Endowment Fund for Neuroscience administers four awards which support young and established neuroscientists and encourage interdisciplinary collaboration: * Memory and Cognitive Disorders Awards * Neuroscience of Brain Disorders Awards * Scholar Awards * Technological Innovations in Neuroscience Awards Mr. McKnight, who led the 3M company for three decades, had a personal interest in memory and its diseases. He chose to set aside part of his legacy to bring hope to those suffering from brain injury or disease and cognitive impairment.

Proper citation: McKnight Endowment Fund for Neuroscience (RRID:SCR_008771) Copy   

•   Source: SciCrunch Registry
  

http://genome.ufl.edu/rivalab/pasta/

A complete pipeline for the analysis of alternative splicing using RNA-Sequencing data.

Proper citation: PASTA (RRID:SCR_008770) Copy   

•   Source: SciCrunch Registry